Exploring the Potential Role of CYP2C19 Genetic Variability in Cenobamate Treatment

<b>Background:</b> Cenobamate is a novel antiseizure medication with potential interactions involving cytochrome P450 enzymes, including CYP2C19. Genetic variability in CYP2C19 may influence drug metabolism and tolerability, although its clinical relevance in cenobamate-treated patients...

Full description

Bibliographic Details
Published in:Applied Sciences
Main Authors: Giovanni Falcicchio, Valeria Delmonte, Teresa Francavilla, Alessandro Introna, Maria Addolorata Mariggiò, Mariella Pafundi, Mirko Perrone, Angela Vinella, Emilio Russo
Format: Article
Language:English
Published: MDPI AG 2026-06-01
Subjects:
epilepsy
cenobamate
CYP2C19
pharmacogenetics
adverse events
precision medicine
Online Access:https://www.mdpi.com/2076-3417/16/11/5679

Internet

https://www.mdpi.com/2076-3417/16/11/5679

Similar Items